 thrombolyt pharmacokinet properti chimer tissue-typ urokinase-typ plasminogen activ background chimer a-chain tissue-typ plasminogen activ t-pa catalyt domain urokinase-typ plasminogen activ u-pa intact enzymat characterist u-pa partial fibrin-bind properti t-pa thrombolyt properti anim model compar superior single-chain u-pa scu-pa delet finger growth factor domain t-pa-delta fe/scu-pa- chimera reduc affin fibrin method result detail investig thrombolyt potenc pharmacokinet t-pa u-pa chimera quantit anim model thrombolysi hamster pulmonari embol rabbit jugular vein thrombosi baboon femor vein thrombosi thrombolyt potenc percent lysi milligram compound kilogram bodi weight t-pa-delta fe/scu-pa- recombin scu-pa rscu-pa saruplas maxim rate versu lysi milligram compound kilogram bodi weight mean sem hamster versu lysi milligram compound kilogram bodi weight mean sem rabbit versu lysi milligram compound kilogram bodi weight baboon specif thrombolyt activ percent lysi millilit steady-st plasma level t-pa-delta fe/scu-pa- differ rscu-pa hamster versu lysi millilit antigen level rscu-pa rabbit versu lysi millilit antigen level dog combin femor vein blood clot platelet-rich femor arteri evers graft thrombosi mg/kg bodi wt bolu inject t-pa-delta fe/scu-pa- venou clot lysi mg/kg rscu-pa arteri side frequent dog dog persist dog none dog recan bolu inject hamster rabbit baboon t-pa-delta fe/scu-pa- fourfold initi half-lif rscu-pa plasma clearanc sixfold hamster rabbit baboon conclus result t-pa-delta fe/scu-pa- thrombolyt potenc venou arteri thrombi vivo clearanc specif thrombolyt activ properti chimera use thrombolyt therapi bolu administr patient thromboembol diseas